MedPath

SWOG

SWOG logo
πŸ‡ΊπŸ‡ΈUnited States
Ownership
Private, Subsidiary
Established
1956-01-01
Employees
101
Market Cap
-
Website
http://www.swog.org
Clinical Trials
Related News

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Phase 2
Completed
Conditions
Esophageal Cancer
Gastric Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2012-06-14
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
61
Registration Number
NCT00012363
Locations
πŸ‡ΊπŸ‡Έ

CCOP - Atlanta Regional, Atlanta, Georgia, United States

πŸ‡ΊπŸ‡Έ

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States

πŸ‡ΊπŸ‡Έ

Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States

and more 93 locations

S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Interventions
Biological: filgrastim
Biological: rituximab
First Posted Date
2003-01-27
Last Posted Date
2012-11-01
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
56
Registration Number
NCT00041132

S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Phase 3
Completed
Conditions
Lung Cancer
Interventions
Procedure: conventional surgery
First Posted Date
2003-01-27
Last Posted Date
2013-01-31
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
354
Registration Number
NCT00004011
Locations
πŸ‡ΊπŸ‡Έ

Abramson Cancer Center at University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, United States

πŸ‡ΊπŸ‡Έ

Mount Diablo Medical Center, Concord, California, United States

πŸ‡¨πŸ‡¦

Doctor Leon Richard Oncology Centre, Moncton, New Brunswick, Canada

and more 284 locations

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Biological: filgrastim
First Posted Date
2003-01-27
Last Posted Date
2013-01-24
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
95
Registration Number
NCT00015938
Locations
πŸ‡ΊπŸ‡Έ

Veterans Affairs Medical Center - Shreveport, Shreveport, Louisiana, United States

πŸ‡ΊπŸ‡Έ

Providence Hospital - Southfield, Southfield, Michigan, United States

πŸ‡ΊπŸ‡Έ

CCOP - Cancer Research for the Ozarks, Springfield, Missouri, United States

and more 96 locations

S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer

Phase 3
Terminated
Conditions
Breast Cancer
Interventions
Procedure: surgery
Radiation: radiation therapy
First Posted Date
2003-01-27
Last Posted Date
2013-01-24
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
98
Registration Number
NCT00005983
Locations
πŸ‡¨πŸ‡¦

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada

S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Biological: filgrastim
Procedure: surgery
First Posted Date
2003-01-27
Last Posted Date
2013-01-24
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
399
Registration Number
NCT00016406
Locations
πŸ‡ΊπŸ‡Έ

Lenoir Memorial Cancer Center, Kinston, North Carolina, United States

πŸ‡ΊπŸ‡Έ

Holland Community Hospital, Holland, Michigan, United States

πŸ‡ΊπŸ‡Έ

Good Samaritan Cancer Center, Puyallup, Washington, United States

and more 309 locations

S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer

Phase 2
Terminated
Conditions
Breast Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2013-01-24
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
27
Registration Number
NCT00025493

S9912 Combination Chemo in Stage III Ovarian Cancer,

Phase 2
Completed
Conditions
Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2013-01-04
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
68
Registration Number
NCT00003896
Locations
πŸ‡ΊπŸ‡Έ

Munson Medical Center, Traverse City, Michigan, United States

πŸ‡ΊπŸ‡Έ

David C. Pratt Cancer Center at St. John's Mercy, St. Louis, Missouri, United States

πŸ‡ΊπŸ‡Έ

Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States

and more 101 locations

S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed

Phase 2
Completed
Conditions
Colorectal Cancer
Interventions
First Posted Date
2003-01-27
Last Posted Date
2013-01-03
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
29
Registration Number
NCT00049335
Locations
πŸ‡ΊπŸ‡Έ

MBCCOP - Gulf Coast, Mobile, Alabama, United States

πŸ‡ΊπŸ‡Έ

CCOP - Atlanta Regional, Atlanta, Georgia, United States

πŸ‡ΊπŸ‡Έ

CCOP - Central Illinois, Decatur, Illinois, United States

and more 87 locations

S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors

Phase 2
Completed
Conditions
Gastrointestinal Stromal Tumor
Interventions
First Posted Date
2003-01-27
Last Posted Date
2013-01-03
Lead Sponsor
SWOG Cancer Research Network
Target Recruit Count
25
Registration Number
NCT00005597
Locations
πŸ‡ΊπŸ‡Έ

MBCCOP - Gulf Coast, Mobile, Alabama, United States

πŸ‡ΊπŸ‡Έ

CCOP - Beaumont, Royal Oak, Michigan, United States

πŸ‡ΊπŸ‡Έ

Veterans Affairs Medical Center - West Los Angeles, Los Angeles, California, United States

and more 103 locations
Β© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy